Trastuzumab emtansine - HY-P9921
Nur noch %1 verfügbar
Catalog #
HY-P9921
Ab
826,00 €
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P9921/Trastuzumab-emtansine-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | Ado-Trastuzumab emtansine; PRO132365; T-DM 1 |
| CAS | 1018448-65-1 |
| Storage | -80°C, protect from light |
| MWT | 148000 (average) |
| Solubility | H2O |
| Clinical Information | Launched |
| Target | Antibody-Drug Conjugates (ADCs);EGFR |
| Application: | Cancer-programmed cell death |
|---|